Team:UB Indonesia/backup
From 2014.igem.org
(Difference between revisions)
Line 180: | Line 180: | ||
<b>4. VECTOR</b><br> | <b>4. VECTOR</b><br> | ||
For the vector for our TALEs, we received help from Lucas Schneider (member of Freiburg Team 2012) and Nicole Densch (Labmanager from <a href="http://www.bioss.uni-freiburg.de/cms/2766.html">BIOSS</a>, Freiburg). We request the pTALEN and pTAL – TF from BIOSS and sent it to us on Whatman paper. Based on Sanjana et al. (2013), TALE-TFs are constructed by replacing the natural activation domain within the TALE C-term with the synthetic transcription activation domain VP64.</p> | For the vector for our TALEs, we received help from Lucas Schneider (member of Freiburg Team 2012) and Nicole Densch (Labmanager from <a href="http://www.bioss.uni-freiburg.de/cms/2766.html">BIOSS</a>, Freiburg). We request the pTALEN and pTAL – TF from BIOSS and sent it to us on Whatman paper. Based on Sanjana et al. (2013), TALE-TFs are constructed by replacing the natural activation domain within the TALE C-term with the synthetic transcription activation domain VP64.</p> | ||
- | <center><img src="https://static.igem.org/mediawiki/2014/7/7d/UB-PTALE-TF.jpg"> | + | <center><img src="https://static.igem.org/mediawiki/2014/7/7d/UB-PTALE-TF.jpg"><br> |
Figure 2. TALEs can be used to generate custom transcription factors (TALE-TFs) and modulate the transcription of endogenous genes from the genome (Sanjana et al., 2013) | Figure 2. TALEs can be used to generate custom transcription factors (TALE-TFs) and modulate the transcription of endogenous genes from the genome (Sanjana et al., 2013) | ||
</center><br> | </center><br> | ||
Line 186: | Line 186: | ||
TALENs are constructed by fusing a C-term truncation (+63aa) of the TALE DNA binding domain with the non-specific FokI endonuclease catalytic domain. TALENs form dimers through binding to two target sequences separated by ~17 bases (Sanjana et al., 2013). | TALENs are constructed by fusing a C-term truncation (+63aa) of the TALE DNA binding domain with the non-specific FokI endonuclease catalytic domain. TALENs form dimers through binding to two target sequences separated by ~17 bases (Sanjana et al., 2013). | ||
</p><br> | </p><br> | ||
- | <center><img src="https://static.igem.org/mediawiki/2014/5/51/UB-PTALEN.jpg"> | + | <center><img src="https://static.igem.org/mediawiki/2014/5/51/UB-PTALEN.jpg"><br> |
Figure 3. TALE nucleases (TALENs) can be used to generate site-specific double strand breaks to facilitate genome editing through non-homologous repair or homology-directed repair (Sanjana et al., 2013) | Figure 3. TALE nucleases (TALENs) can be used to generate site-specific double strand breaks to facilitate genome editing through non-homologous repair or homology-directed repair (Sanjana et al., 2013) | ||
</center><br><br> | </center><br><br> | ||
Line 193: | Line 193: | ||
As we’ve said before that we inspired by the <a href="https://2013.igem.org/Team:Calgary">Calgary Team 2013</a>’s project, so we decided to learn the linker from previous work by them. The E/K coil is a heterodimeric coiled-coil that often used for biosensors and as an expression and affinity purification tag. The E coil contains all glutamic acid residues and the K coil contains all lysine residues. This coiled-coil can be found in a wide variety of proteins and contain a single type of secondary structure or the α-helix. There are two ways to increasing the stability of this sequence: the hydrophobic core of the coiled-coil (positions at a and d) and the α-helical propensity of surface esposed positions at b, c, e, f, and g (Litowski, 2002). | As we’ve said before that we inspired by the <a href="https://2013.igem.org/Team:Calgary">Calgary Team 2013</a>’s project, so we decided to learn the linker from previous work by them. The E/K coil is a heterodimeric coiled-coil that often used for biosensors and as an expression and affinity purification tag. The E coil contains all glutamic acid residues and the K coil contains all lysine residues. This coiled-coil can be found in a wide variety of proteins and contain a single type of secondary structure or the α-helix. There are two ways to increasing the stability of this sequence: the hydrophobic core of the coiled-coil (positions at a and d) and the α-helical propensity of surface esposed positions at b, c, e, f, and g (Litowski, 2002). | ||
</p><br> | </p><br> | ||
- | <center><img src="https://static.igem.org/mediawiki/2014/2/29/UB-Helical_coil.jpg"> | + | <center><img src="https://static.igem.org/mediawiki/2014/2/29/UB-Helical_coil.jpg"><br> |
Figure 4. Helical wheel of the E4/K4 heterodimer (Litowski, 2002) | Figure 4. Helical wheel of the E4/K4 heterodimer (Litowski, 2002) | ||
</center><br> | </center><br> | ||
Line 206: | Line 206: | ||
This is one of chromoprotein collection from <a href="https://2012.igem.org/Team:Uppsala_University">Uppsala Team 2012</a>. This chromoprotein will be connected to detector using linker. amilCP bind to E coil and interact with Tale-K coil. This reporter show the presence of Human Papilloma Virus by colour change. When the HPV DNA is bind to detector, spesific sequence of HPV will be recognized and blue colour appears in the second strip. The Colour intensity will be detected in our software and we can determined the risk level of cervical cancer disease. Dark blue colour show the amount of DNA from HPV 16 and 18 is high and indicate the patient get severe cervical cancer. | This is one of chromoprotein collection from <a href="https://2012.igem.org/Team:Uppsala_University">Uppsala Team 2012</a>. This chromoprotein will be connected to detector using linker. amilCP bind to E coil and interact with Tale-K coil. This reporter show the presence of Human Papilloma Virus by colour change. When the HPV DNA is bind to detector, spesific sequence of HPV will be recognized and blue colour appears in the second strip. The Colour intensity will be detected in our software and we can determined the risk level of cervical cancer disease. Dark blue colour show the amount of DNA from HPV 16 and 18 is high and indicate the patient get severe cervical cancer. | ||
</p><br> | </p><br> | ||
- | <center><img src="https://static.igem.org/mediawiki/2014/7/76/UB-AMILcp_FIX.jpg"> | + | <center><img src="https://static.igem.org/mediawiki/2014/7/76/UB-AMILcp_FIX.jpg"><br> |
Figure 6. amilCP with his tag and C-terminus E coil | Figure 6. amilCP with his tag and C-terminus E coil | ||
</center><br><br> | </center><br><br> |
Revision as of 14:28, 16 October 2014